Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail Kosiborod, Adriaan A. Voors, Josep Comín‐Colet et al.|Circulation|2022Cited by 142
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Cardiac failure review|2020Cited by 67